| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/18/2002 | EP1265904A1 Novel positive allosteric ampa receptor modulators (paarm), method for the production and use thereof as medicaments |
| 12/18/2002 | EP1265903A1 Thiepino[3,2-b]dihydropyridines and related compositions and methods |
| 12/18/2002 | EP1265901A2 Process for the preparation of midazolam |
| 12/18/2002 | EP1265900A1 1,5-disubstituted-3,4-dihydro-1h-pyrimido 4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases |
| 12/18/2002 | EP1265899A1 Pyrimidine compounds and their use as modulators of chemokine receptor activity |
| 12/18/2002 | EP1265898A2 1,8-NAPHTHALIMIDE IMIDAZO 4,5,1- i de /i ]ACRIDONES WITH ANTI-TUMOR ACTIVITY |
| 12/18/2002 | EP1265896A1 4-hydroxy-1,8-naphthyridine-3-carboxamides as antiviral agents |
| 12/18/2002 | EP1265895A1 4-oxo-1,4-dihydro 1,8]naphthyridine-3-carboxamides as antiviral agents |
| 12/18/2002 | EP1265894A1 Crystalline form vii of cabergoline |
| 12/18/2002 | EP1265893A1 Hydrochloride salts of 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione |
| 12/18/2002 | EP1265891A2 Novel lipoic acid heterocyclic or benzene derivatives, preparation and use thereof as medicines |
| 12/18/2002 | EP1265887A2 Carbocyclic side chain containing metalloprotease inhibitors |
| 12/18/2002 | EP1265886A2 Carbocyclic side chain containing, n-substituted metalloprotease inhibitors |
| 12/18/2002 | EP1265883A1 Method for the preparation of citalopram |
| 12/18/2002 | EP1265882A1 Method for the preparation of citalopram |
| 12/18/2002 | EP1265881A1 Stepwise alkylation of 5-substituted 1-(4-fluorophenyl)-1,3-dihydroisobenzofurans |
| 12/18/2002 | EP1265880A1 Method for the preparation of citalopram |
| 12/18/2002 | EP1265879A1 Allomorph isomer z hydrochloride of ranitidine |
| 12/18/2002 | EP1265878A1 A process for the preparation of epothiline analogs and intermediates |
| 12/18/2002 | EP1265873A2 4-oxo-1,4-dihydro-3-cinnolinecarboxamides as antiviral agents |
| 12/18/2002 | EP1265872A1 4-hydroxycinnoline-3-carboxyamides as antiviral agents |
| 12/18/2002 | EP1265871A1 Pyridazinyl phenyl hydrazones useful against congestive heart failure |
| 12/18/2002 | EP1265870A1 New ccr5 modulators: benzimidazoles or benzotriazoles |
| 12/18/2002 | EP1265868A2 Dibenzo (b,f) azepine intermediates |
| 12/18/2002 | EP1265867A1 Novel malonic acid derivates, processes for their preparation, their use as inhibitor of factor xa activity and pharmaceutical compositions containing them |
| 12/18/2002 | EP1265866A2 Aryl substituted pyridines, pyrimidines, pyrazines and triazines and the use thereof |
| 12/18/2002 | EP1265865A2 Difluorobutyric acid derivatives and their use as metalloprotease inhibitors |
| 12/18/2002 | EP1265864A1 Heterocyclic side chain containing, n-substituted metalloprotease inhibitors |
| 12/18/2002 | EP1265863A1 Heterocyclic side chain containing metalloprotease inhibitors |
| 12/18/2002 | EP1265862A2 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 12/18/2002 | EP1265860A1 Amidino compound and salts thereof useful as nitric oxide synthase inhibitors |
| 12/18/2002 | EP1265859A2 Amidino compounds useful as nitric oxide synthase inhibitors |
| 12/18/2002 | EP1265857A1 Sulfonamide derivatives |
| 12/18/2002 | EP1265855A1 Novel cd23 inhibitors |
| 12/18/2002 | EP1265854A1 Sponge antitumor compounds |
| 12/18/2002 | EP1265853A1 Carboxylic acid derivatives as ip antagonists |
| 12/18/2002 | EP1265849A2 Compounds and methods to treat alzheimer's disease |
| 12/18/2002 | EP1265848A2 Amines substituted with a dihydronaphthalenyl, crhomenyl, or thiochromenyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity |
| 12/18/2002 | EP1265841A2 Process for the preparation of sodium salts of statins |
| 12/18/2002 | EP1265839A1 Compounds active at the glucocorticoid receptor |
| 12/18/2002 | EP1265838A1 Novel fatty acid analogous |
| 12/18/2002 | EP1265683A1 Methods for extraction and reaction using supercritical fluids |
| 12/18/2002 | EP1265637A2 Compositions and methods for affecting osteogenesis |
| 12/18/2002 | EP1265636A2 Improved treatment of neovascularization |
| 12/18/2002 | EP1265623A2 Pharmaceutical compositions including alginates |
| 12/18/2002 | EP1265622A2 Treatment of herpes infection using immunomodulatory polynucleotide sequences |
| 12/18/2002 | EP1265621A2 Use of cdp-choline for the prophylactic treatment of cerebral ischemia |
| 12/18/2002 | EP1265620A2 Mono- and disaccharides for the treatment of nitric oxide related disorders |
| 12/18/2002 | EP1265618A1 Anaesthetic composition |
| 12/18/2002 | EP1265617A2 Novel topical oestroprogestational compositions with systemic effect |
| 12/18/2002 | EP1265616A2 Hormone replacement therapy using a combination of conjugated estrogens and medroxyprogesterone acetate |
| 12/18/2002 | EP1265615A2 Novel combination of non-sedative anti-histamines containing substances which influence the action of leukotriene, for treating rhinitis/conjunctivitis |
| 12/18/2002 | EP1265614A1 Novel galenical form for oral administration with prolonged release of molsidomine |
| 12/18/2002 | EP1265613A2 Use of ectoin or ectoin derivatives for the prophylaxis and/or treatment of uv-induced immunosuppression |
| 12/18/2002 | EP1265612A1 Pharmaceutical composition comprising pemetrexed together with monothioglycerol, l-cystein or thioglycolic acid |
| 12/18/2002 | EP1265611A2 Farnesyl protein transferase inhibitor combinations with taxane compounds |
| 12/18/2002 | EP1265610A1 Method for reducing or eliminating smoking |
| 12/18/2002 | EP1265609A1 Methods for treating sexual dysfunction with apomorphine at specified plasma concentration levels |
| 12/18/2002 | EP1265608A2 Oxazolidinone tablet formulation |
| 12/18/2002 | EP1265607A2 METHOD FOR THE TREATMENT OF RENAL DYSFUNCTION WITH sPLA 2 INHIBITORS |
| 12/18/2002 | EP1265606A1 Cell adhesion inhibitors |
| 12/18/2002 | EP1265605A1 $g(b)-TURN PEPTIDOMIMETIC CYCLIC COMPOUNDS |
| 12/18/2002 | EP1265603A2 Il-8 receptor antagonists |
| 12/18/2002 | EP1265602A2 Use of substances modulating the expression or the function of a protein involved in the cell cycle for treating or preventing acute neural injuries |
| 12/18/2002 | EP1265601A2 Method for treating ocular pain |
| 12/18/2002 | EP1265600A2 Headache and colic relief composition with asafetida and method of use thereof |
| 12/18/2002 | EP1265599A1 Antibiotic composition with inhibitor |
| 12/18/2002 | EP1265596A2 Medical emulsion for lubrication and delivery of drugs |
| 12/18/2002 | EP1265595A2 Stabilized ascorbic acid solutions |
| 12/18/2002 | EP1265579A1 Container for linezolid intravenous solution |
| 12/18/2002 | EP1265483A2 Use of phenylethylamine derivatives for the anitmicrobial treatment of surfaces |
| 12/18/2002 | EP1149096B1 Tricyclic pyridine n-oxides vasopressin agonists |
| 12/18/2002 | EP1124814B1 Aromatic derivatives and iron complexes thereof for the use as normalising agents of the iron level |
| 12/18/2002 | EP1121088B1 Use of nanoscale sterols and sterol esters |
| 12/18/2002 | EP1119564B1 Aryl- 4-fluoro-4- (2-pyridin-2-yl-ethylamino)-methyl]-piperidin-1-yl -methanone derivatives as 5-ht1 receptor antagonists |
| 12/18/2002 | EP1104420B1 Substituted 1,8-naphthyridin-4(1h)-ones as phosphodiesterase 4 inhibitors |
| 12/18/2002 | EP1098898B1 Calcium (3s) tetrahydro-3-furanyl(1s,2r)-3-[[(4-aminophenyl) sulfonyl] (isobutyl) amino] -1-benzyl-2- (phosphonooxy) propylcarbamate |
| 12/18/2002 | EP1086101B1 Beta-carboline compounds |
| 12/18/2002 | EP1079833A4 Cocaine receptor binding ligands |
| 12/18/2002 | EP1077616B1 Nutritional product for a person having renal failure |
| 12/18/2002 | EP1064273B1 1,3,4-thiadiazoles useful for the treatment of cmv infections |
| 12/18/2002 | EP1053221B1 Lipid mixtures and their use |
| 12/18/2002 | EP1025101B1 Naphtho-imidazo 1,2-a]pyridine derivatives, their preparation and their use in treating central nervous system disorders |
| 12/18/2002 | EP1023062B1 Antibacterial carbapenems, compositions and methods of treatment |
| 12/18/2002 | EP1021180B1 Mixed cyanoacrylate ester compositions |
| 12/18/2002 | EP1017275A4 Polyamine treatment of neurological disorders |
| 12/18/2002 | EP0989847B1 Anti-tumoral therapy agent |
| 12/18/2002 | EP0957088B1 Vitamin d3 derivatives and process for producing the same |
| 12/18/2002 | EP0946721B1 Human growth gene and short stature gene region |
| 12/18/2002 | EP0946502B1 Sulfonamide interleukin-beta converting enzyme inhibitors |
| 12/18/2002 | EP0934300B1 The preparation and use of ortho-sulfonamido heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 12/18/2002 | EP0934078B1 Permeation enhancers for transdermal drug delivery compositions, devices, and methods |
| 12/18/2002 | EP0930889B1 CITRUS PEEL EXTRACT AS 3-HYDROXY-3-METHYLGLUTARYL CoA(HMG-CoA) REDUCTASE INHIBITOR |
| 12/18/2002 | EP0930884B1 Chronic use of lorazepam and diphenhydramine |
| 12/18/2002 | EP0929522B1 Insect-repellent formulations |
| 12/18/2002 | EP0925503B1 Materials and methods relating to the diagnosis and treatment of diabetes and obesity |
| 12/18/2002 | EP0912584B1 New bis-platinum complexes with polyamine ligands as antitumor agents |
| 12/18/2002 | EP0910328B1 Aqueous nacreous lustre concentrate |
| 12/18/2002 | EP0898477B1 Topical administration of premafloxacin for the treatment of systemic bacterial diseases |
| 12/18/2002 | EP0891344B1 Alpha-1 adrenergic receptor antagonists |